Arcelio J Malcolm

Title: Arcelio J Malcolm: Innovator in Pharmaceutical Advancements

Introduction

Arcelio J Malcolm is a notable inventor based in Baton Rouge, Louisiana, recognized for his significant contributions to the pharmaceutical industry. With a total of 12 patents to his name, Malcolm has developed innovative solutions that enhance the efficacy and utility of various pharmaceutical compounds.

Latest Patents

Among his latest patents is the invention of high ibuprofen content granules and their preparation for use in pharmaceutical dosage forms. This patent describes granules composed of a substantial amount of ibuprofen, along with at least one pharmaceutically-acceptable super disintegrant and binder. The methods for preparing these granules are detailed, highlighting their usefulness in forming solid dosage forms such as filled capsules or compressed tablets. Another significant patent involves the preparation of a Lucas reagent of enhanced utility. This invention introduces gaseous anhydrous hydrogen chloride into an aqueous solution of zinc chloride, resulting in a more efficient Lucas reagent compared to traditional methods. The improved reaction rate and higher conversion to levo-menthyl chloride demonstrate the advantages of this innovative approach.

Career Highlights

Throughout his career, Arcelio J Malcolm has worked with prominent companies such as Albemarle Corporation and Ethyl Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and has allowed him to develop groundbreaking technologies.

Collaborations

Malcolm has collaborated with notable colleagues, including K Pushpananda Senaratne and Felix M Orihuela. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in the field.

Conclusion

Arcelio J Malcolm's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His innovative approaches continue to shape the future of pharmaceutical formulations and enhance the effectiveness of medications.